Vanderbilt University Medical Center

According to SRTR data from November 2025, Vanderbilt University Medical Center reports a 1-year graft survival rate of 92.9% for kidney-pancreas transplants, compared to a national average of 94.9%. The 3-year survival rate is 92.9%. Survival rates are risk-adjusted estimates for a historical cohort, not a forecast for a named patient.

Vanderbilt University Medical Center reported 36 kidney-pancreas transplants in the current SRTR Program-Specific Report cohort. That count is inventory from the joined program row, not a quality grade.

SRTR reports approximately 16 candidates on this program's kidney-pancreas waiting list in the November 2025 cohort, with about 6 waitlist additions recorded in the same report window. Stock (inventory) and additions (flow) are different SRTR fields; this page does not estimate an individual's wait.

SRTR records about 6 kidney-pancreas waitlist additions for Vanderbilt University Medical Center in the November 2025 Program-Specific Report window (organ-class mean among ranked programs: 15). Additions are cohort flow, not a predicted wait time or a recommendation.

Vanderbilt University Medical Center ranks #77 of 106 reporting kidney-pancreas programs by 1-year graft survival in this cohort. The center's rate is 2.1 percentage points below the national risk-adjusted benchmark. Rankings exclude programs below SRTR's published case-volume floor.

This page reports the program's SRTR 1-year and 3-year graft survival estimates, transplants performed, waitlist stock, waitlist additions (flow), and the risk-adjusted national benchmark for kidney-pancreas. Rank order is among programs that meet SRTR's published case-volume floor. None of those fields is a recommendation to choose or avoid the center.